We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XL
26
DELISTED
XL Group Ltd.
XL
| $26.8M | 0.57% |
611,920
+310,450
| +103% | +$13.1M |
|
|
27
Humana
HUM
$47B
| $26.8M | 0.57% |
+111,320
| New | +$25.2M |
|
28
Citizens Financial Group
CFG
$29.9B
| $26.8M | 0.57% |
750,565
-95,310
| -11% | -$3.38M |
|
29
Prudential Financial
PRU
$40.6B
| $26.3M | 0.56% |
242,839
-33,590
| -12% | -$3.57M |
|
30
Electronic Arts
EA
$52.4B
| $26M | 0.56% |
245,717
-26,200
| -10% | -$2.7M |
|
31
Bunge Global
BG
$23.9B
| $26M | 0.56% |
347,939
-45,850
| -12% | -$3.49M |
|
32
Visteon
VC
$2.72B
| $25.9M | 0.55% |
253,583
-6,670
| -3% | -$659K |
|
33
Centene
CNC
$31.6B
| $25.5M | 0.54% |
637,290
-150,180
| -19% | -$5.67M |
|
34
East-West Bancorp
EWBC
$17.7B
| $25.4M | 0.54% |
434,222
-19,292
| -4% | -$1.06M |
|
35
NVR
NVR
$16.7B
| $25.4M | 0.54% |
10,541
-4,592
| -30% | -$10.4M |
|
|
ARRS
36
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $25.1M | 0.54% |
895,577
-273,500
| -23% | -$7.51M |
|
37
PNC Financial Services
PNC
$98.8B
| $24.8M | 0.53% |
198,710
-36,335
| -15% | -$4.38M |
|
38
HP
HPQ
$22.6B
| $24.5M | 0.52% |
1,399,970
-242,100
| -15% | -$4.44M |
|
39
Eli Lilly
LLY
$1.06T
| $24.4M | 0.52% |
296,300
-45,340
| -13% | -$3.7M |
|
40
PepsiCo
PEP
$184B
| $24.4M | 0.52% |
211,050
+92,030
| +77% | +$10.6M |
|
41
Synopsys
SNPS
$71.6B
| $24.2M | 0.52% |
332,391
-10,659
| -3% | -$784K |
|
42
Ford
F
$56.3B
| $24.1M | 0.52% |
2,154,530
-258,120
| -11% | -$2.88M |
|
43
Intel
INTC
$510B
| $23.9M | 0.51% |
707,930
-62,950
| -8% | -$2.25M |
|
|
CMA
44
DELISTED
Comerica
CMA
| $23.9M | 0.51% |
326,030
-26,280
| -7% | -$1.84M |
|
45
Edwards Lifesciences
EW
$48.3B
| $23.6M | 0.51% |
599,964
-312,180
| -34% | -$11.4M |
|
|
JNPR
46
DELISTED
Juniper Networks
JNPR
| $23.5M | 0.5% |
844,200
-98,620
| -10% | -$2.87M |
|
47
Landstar System
LSTR
$7.02B
| $23.4M | 0.5% |
273,215
-20,830
| -7% | -$1.77M |
|
48
AGCO
AGCO
$8.65B
| $23.2M | 0.5% |
343,641
+13,030
| +4% | +$832K |
|
|
STI
49
DELISTED
SunTrust Banks, Inc.
STI
| $23M | 0.49% |
405,296
+7,410
| +2% | +$412K |
|
50
Vertex Pharmaceuticals
VRTX
$121B
| $22.7M | 0.48% |
175,854
-39,756
| -18% | -$4.79M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.